PsyBio Therapeutics Financials
| PSYBF Stock | USD 0.0001 0.00 0.00% |
PsyBio |
Understanding current and past PsyBio Therapeutics Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of PsyBio Therapeutics' financial statements are interrelated, with each one affecting the others. For example, an increase in PsyBio Therapeutics' assets may result in an increase in income on the income statement.
PsyBio Therapeutics Stock Summary
PsyBio Therapeutics competes with Rigel Pharmaceuticals, Geron, Verastem, Immutep, and Elevation Oncology. PsyBio Therapeutics Corp., a biotechnology company, focuses on the research, development, and commercialization of psychedelic-inspired regulated medicines for the treatment of mental health and other disorders in the United States. Psybio Therapeautics operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 4 people.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| Business Address | 4400 West Sample |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | www.psybiolife.com |
| Phone | 513 449 9585 |
| Currency | USD - US Dollar |
PsyBio Therapeutics Key Financial Ratios
There are many critical financial ratios that PsyBio Therapeutics' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that PsyBio Therapeutics Corp reports annually and quarterly.PsyBio Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining PsyBio Therapeutics's current stock value. Our valuation model uses many indicators to compare PsyBio Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across PsyBio Therapeutics competition to find correlations between indicators driving PsyBio Therapeutics's intrinsic value. More Info.PsyBio Therapeutics Corp is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the PsyBio Therapeutics' earnings, one of the primary drivers of an investment's value.PsyBio Therapeutics Corp Systematic Risk
PsyBio Therapeutics' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. PsyBio Therapeutics volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on PsyBio Therapeutics Corp correlated with the market. If Beta is less than 0 PsyBio Therapeutics generally moves in the opposite direction as compared to the market. If PsyBio Therapeutics Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one PsyBio Therapeutics Corp is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of PsyBio Therapeutics is generally in the same direction as the market. If Beta > 1 PsyBio Therapeutics moves generally in the same direction as, but more than the movement of the benchmark.
PsyBio Therapeutics December 1, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of PsyBio Therapeutics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of PsyBio Therapeutics Corp. We use our internally-developed statistical techniques to arrive at the intrinsic value of PsyBio Therapeutics Corp based on widely used predictive technical indicators. In general, we focus on analyzing PsyBio Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build PsyBio Therapeutics's daily price indicators and compare them against related drivers.
| Information Ratio | 0.122 | |||
| Maximum Drawdown | 20998.0 |
Complementary Tools for PsyBio Pink Sheet analysis
When running PsyBio Therapeutics' price analysis, check to measure PsyBio Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PsyBio Therapeutics is operating at the current time. Most of PsyBio Therapeutics' value examination focuses on studying past and present price action to predict the probability of PsyBio Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PsyBio Therapeutics' price. Additionally, you may evaluate how the addition of PsyBio Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Stocks Directory Find actively traded stocks across global markets | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |